Date | Title | Description | |
---|---|---|---|
24 Feb 2021 | About corporate governance | The Company informs about the agreements adopted by the Board of Directors | Download |
27 Nov 2020 | On business and financial situation | The Company publishes the results of the PRISMA-3 study of the efficacy and safety of Doria® in schizophrenic patients in the journal npj Schizophrenia | Download |
09 Jul 2020 | On business and financial situation | ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate | Download |
Pages
Date | Title | Description | |
---|---|---|---|
04 Oct 2021 | Liquidity and counterparty agreements | Download | |
01 Sep 2021 | On business and financial situation | ROVI informs about the joint statement from Moderna and Takeda on the investigation of suspended lots of the vaccine | Download |
28 Jul 2021 | On business and financial situation | The company releases the press release related to first half 2021 financial results | Download |
28 Jul 2021 | On business and financial situation | ROVI releases the first half 2021 results presentation | Download |
05 Jul 2021 | Liquidity contracts and specialists | Liquidity contract: transactions conducted in the second quarter of 2021 | Download |
Pages
Date | Title | Description | |
---|---|---|---|
18 Nov 2015 | Convocatorias y acuerdos de Juntas y Asambleas generales | Download | |
22 Oct 2015 | información sobre resultados | Download | |
22 Oct 2015 | información sobre resultados (2) | Download | |
21 Oct 2015 | Otros sobre Gobierno Corporativo | Download | |
16 Oct 2015 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | Download |